Ewa Hoffmann
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Nicotinic Acetylcholine Receptors Study 4
- Receptor Mechanisms and Signaling 3
-
- Pharmacogenetics and Drug Metabolism 8
- Co-authors
- Rachel F. Tyndale (21 shared papers)Sharon Miksys (5 shared papers)Edward M. Sellers (5 shared papers)Deborah C. Mash (2 shared papers)Kerri A. Schoedel (1 shared paper)Caryn Lerman (2 shared papers)Laurent Bodin (2 shared papers)Marilyn Zeman (2 shared papers)
- Journals
- Molecular Pharmacology (2 papers)British Journal of Pharmacology (2 papers)Biological Psychiatry (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- CanadaUnited StatesRussia
In The Last Decade
Ewa Hoffmann
21 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 97
- Pharmacology 621
- Biochemistry 136
- Physiology 403
- Biological Psychiatry 33
- Cellular and Molecular Neuroscience 191
Countries citing papers authored by Ewa Hoffmann
This map shows the geographic impact of Ewa Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Hoffmann more than expected).
Fields of papers citing papers by Ewa Hoffmann
This network shows the impact of papers produced by Ewa Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Hoffmann. The network helps show where Ewa Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Ewa Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 245 | |
| 2 | 2000 | 202 | |
| 3 | 2002 | 133 | |
| 4 | 2013 | 124 | |
| 5 | 2003 | 122 | |
| 6 | 2002 | 118 | |
| 7 | 2007 | 110 | |
| 8 | 2000 | 106 | |
| 9 | 2011 | 83 | |
| 10 | 2007 | 78 | |
| 11 | 2008 | 73 | |
| 12 | 2008 | 61 | |
| 13 | 2009 | 57 | |
| 14 | 2016 | 36 | |
| 15 | 2013 | 32 | |
| 16 | 2014 | 28 | |
| 17 | 2000 | 23 | |
| 18 | 2000 | 15 | |
| 19 | Pentobarbital decreases the gamma-aminobutyric acidA receptor subunit gamma-2 long/short mRNA ratio by a mechanism distinct from receptor occupation. | 1997 | 10 |
| 20 | 1997 | 4 |
About Ewa Hoffmann
Ewa Hoffmann is a scholar working on Molecular Biology, Pharmacology, Cellular and Molecular Neuroscience, Organic Chemistry and Physiology, having authored 24 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Neuroscience and Neuropharmacology Research (4 papers), Nicotinic Acetylcholine Receptors Study (4 papers), Synthesis and Biological Evaluation (4 papers), Receptor Mechanisms and Signaling (3 papers), Smoking Behavior and Cessation (3 papers), Estrogen and related hormone effects (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Pharmacology (621 citations), Biochemistry (136 citations), Physiology (403 citations), Biological Psychiatry (33 citations) and Cellular and Molecular Neuroscience (191 citations). Ewa Hoffmann has collaborated with scholars based in Canada, United States and Russia. Frequent co-authors include Rachel F. Tyndale, Sharon Miksys, Edward M. Sellers, Deborah C. Mash, Kerri A. Schoedel, Caryn Lerman, Laurent Bodin, Marilyn Zeman, Mohammad I. Zia and Nael Al Koudsi. Their work appears in journals such as Molecular Pharmacology, British Journal of Pharmacology, Biological Psychiatry, Clinical Pharmacology & Therapeutics and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.